FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients cnbc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnbc.com Daily Mail and Mail on Sunday newspapers.
Health: US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.
(Bloomberg) When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlorida’s 125% Surge in Property-
AstraZeneca aims for a 75% revenue boost to $80 billion by 2030, driven by 20 new medicines and growth in existing portfolios. CEO Pascal Soriot has revitalized the drug pipeline with key blockbusters. Analysts anticipate key insights at today's investor day event.
AstraZeneca aims to grow its total revenue by 75% to $80 bn by 2030 business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.